NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The institutions and Governments I listed are the high level associations NWBO has.

The enrollment data on DCVAX-L is not specific at this time. If there is a continuance by the DMC, this will be an opportunity for NWBO to update us on enrollment numbers, because this is info the DMC is allowed to share at interim updates (under their Guidelines). See previous PRANA interim updates on imagine and reach trials for examples.

Results are certainly under wraps on DCVAX-L, phase III, because this is a blinded trial.

Results on Direct are "encouraging" but only a few have gone through early dosing. We will be updated with "glimpses" in the spring and summer.

Sarah Cannon has letter of intent to collaborate in clinical trials on upcoming Europe DCVAX-Direct.

I already gave you the response rate shared by LP in her January webcast, partially related to the Israel compassionate use program.

Note: Other associations with NWBO include:

10. UCLA.

11. University Hospital in Cologne.